Beijing Tiantan Biological Products Co., Ltd.
600161
Rankning i aktier
#4322
Beijing Tiantan Biological Products Co., Ltd., established in 1998 and... Beijing Tiantan Biological Products Co., Ltd., established in 1998 and headquartered in Beijing, China, is actively involved in the full spectrum of blood product operations within China. This includes pioneering research and development, manufacturing, sales, and providing consultancy services. Its comprehensive product line features critical blood-derived medicines such as intravenous immunoglobulin, human albumin, and various specialized human immunoglobulins for conditions like hepatitis B (both standard and freeze-dried formulations) and tetanus, alongside other general human immunoglobulin preparations and intravenous blood system solutions. The company operates as a subsidiary of China National Biotec Group Company Limited.
Aktiekurs
$1.81
Marknadsvärde
$3.59B
Förändring (1 dag)
-0.90%
Förändring (1 år)
-32.39%
Land
CN
Handel Beijing Tiantan Biological Products Co., Ltd. (600161)
Kategori
Healthcare
Aktiekurshistorik för Beijing Tiantan Biological Products Co., Ltd. (600161)
Högsta slutkurs: $1.81 den 2026-10-01
Lägsta slutkurs: $0.07 den 2005-07-01
Lägsta slutkurs: $0.07 den 2005-07-01
Aktiekurshistorik för Beijing Tiantan Biological Products Co., Ltd. från 2005 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | -10.60% |
| 2025 | -18.04% |
| 2024 | -20.40% |
| 2023 | 33.59% |
| 2022 | -13.56% |
| 2021 | -28.42% |
| 2020 | 98.85% |
| 2019 | 45.59% |
| 2018 | -15.66% |
| 2017 | 10.41% |
| 2016 | 19.78% |
| 2015 | 5.68% |
| 2014 | 24.08% |
| 2013 | 90.14% |
| 2012 | -27.39% |
| 2011 | -24.78% |
| 2010 | -11.65% |
| 2009 | 89.78% |
| 2008 | -47.45% |
| 2007 | 135.81% |
| 2006 | 373.09% |
| 2005 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $536.13 | 25.72% |
US
|
|
| $200.12 | 645.31% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $880.01 | 8.09% |
NL
|
